Controlled attenuation parameter (CAP): A novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes

Ultrasound in Medicine and Biology

Volumn 36, Issue 11, 2010, Pages 1825-1835

  Sasso, Magali ^a   Beaugrand, Michel ^b   de Ledinghen, Victor ^c   Douvin, Catherine ^d   Marcellin, Patrick ^e   Poupon, Raoul ^f   Sandrin, Laurent ^a   Miette, Véronique ^a  

^a R and D Department   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e BEAUJON HOSPITAL   (France)

^f HÔPITAL SAINT ANTOINE   (France)

Author keywords

Attenuation; Elastography; Fibroscan ; Liver; Nonalcoholic fatty liver disease; Steato hepatitis; Steatosis; Ultrasound attenuation; VCTE ; Vibration controlled transient elastography

Indexed keywords

ATTENUATION; ELASTOGRAPHY; NON-ALCOHOLIC FATTY LIVER DISEASE; STEATO-HEPATITIS; STEATOSIS; ULTRASOUND ATTENUATION; VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY;

ULTRASONIC APPLICATIONS; ULTRASONIC EFFECTS; ULTRASONIC WAVES; ULTRASONICS;

LIVER;

ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED ATTENUATION PARAMETER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ELASTOGRAPHY; FATTY LIVER; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; RADIOLOGICAL PARAMETERS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION RESEARCH; LIVER EXAMINATION; NON INVASIVE MEASUREMENT; PHANTOM; RADIODIAGNOSIS; RADIODIAGNOSTIC EQUIPMENT AND SUPPLIES; TISSUE SPECIFICITY; VIBRATION CONTROL TRANSIENT ELASTOGRAPHY; ALGORITHM; AREA UNDER THE CURVE; CHRONIC DISEASE; DISEASE COURSE; ECHOGRAPHY; IMAGE QUALITY; METHODOLOGY; NONPARAMETRIC TEST; PILOT STUDY; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY;

ALGORITHMS; AREA UNDER CURVE; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; HUMANS; PHANTOMS, IMAGING; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 77958154016     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.07.005     Document Type: Article

References (45)

1. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
2. Bellentani S., Saccoccio G., Masutti F., Croce L.S., Brandi G., Sasso F., Cristanini G., Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
3. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Grundy S.M., Hobbs H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
4. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
5. Burckhardt C.B. Speckle in Ultrasound B-Mode Scans. IEEE Trans Sonic Ultrason 1978, 25:1-6.
6. Clark J.M., Brancati F.L., Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 2002, 122:1649-1657.
7. Corpechot C., El Naggar A., Poujol-Robert A., Ziol M., Wendum D., Chazouilleres O., de Ledinghen V., Dhumeaux D., Marcellin P., Beaugrand M., Poupon R. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006, 43:1118-1124.
8. de Ledinghen V., Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008, 32:58-67.
9. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
10. Farrell G.C. Fatty liver disease: NASH and related disorders 2004, Blackwell Publishing, Malden, MA, USA.
11. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.
12. Fawcett An introduction to ROC analysis. Pattern Recong Lett 2006, 27:861-874.
13. Friedman M. The use of ranks to avoid the assumption of normality implicit in the analysis of variance. J Am Statist Assoc 1937, 32:675-701.
14. Fujii Y., Taniguchi N., Itoh K., Shigeta K., Wang Y., Tsao J.W., Kumasaki K., Itoh T. A new method for attenuation coefficient measurement in the liver: Comparison with the spectral shift central frequency method. J Ultrasound Med 2002, 21:783-788.
15. Garra B.S., Insana M.F., Shawker T.H., Russell M.A. Quantitative estimation of liver attenuation and echogenicity: Normal state versus diffuse liver disease. Radiology 1987, 162:61-67.
16. Gholam P.M., Flancbaum L., Machan J.T., Charney D.A., Kotler D.P. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 2007, 102:399-408.
17. Gluer C.C., Blake G., Lu Y., Blunt B.A., Jergas M., Genant H.K. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 1995, 5:262-270.
18. Grant A., Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 1999, 45(Suppl. 4):IV1-IV11.
19. Guiu B., Loffroy R., Hillon P., Petit J.M. Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: Urgent need for standardization!. J Hepatol 2009, 51:1082-1083. author reply 3-4.
20. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
21. Jensen JA. Field: A Program for Simulating Ultrasound Systems. Proceedings of 10th Nordic-Baltic Conference on Biomedical Imaging, 1996.
22. Jensen JA, Gandhi D, O'Brien WD. Ultrasound fields in an attenuating medium. Proceedings of IEEE Ultrasonics Symposium, Baltimore, Maryland, 1993.
23. Jensen JA, Nikolov SI. Fast simulation of ultrasound images. Proceedings of IEEE Ultrasonics Symposium. Puerto Rico, 2000.
24. Jensen J.A., Svendsen N.B. Calculation of pressure fields from arbitrarily shaped, apodized, and excited ultrasound transducers. IEEE Trans Ultrason Ferroelectr Freq Control 1992, 39:262-267.
25. Lu Z.F., Zagzebski J.A., Lee F.T. Ultrasound backscatter and attenuation in human liver with diffuse disease. Ultrasound Med Biol 1999, 25:1047-1054.
26. Maklad N.F., Ophir J., Balsara V. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo. Ultrason Imaging 1984, 6:117-125.
27. Marcellin P., Ziol M., Bedossa P., Douvin C., Poupon R., de Ledinghen V., Beaugrand M. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009, 29:242-247.
28. Nahon P., Kettaneh A., Tengher-Barna I., Ziol M., de Ledinghen V., Douvin C., Marcellin P., Ganne-Carrie N., Trinchet J.C., Beaugrand M. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008, 49:1062-1068.
29. Nomura H., Kashiwagi S., Hayashi J., Kajiyama W., Tani S., Goto M. Prevalence of fatty liver in a general population of Okinawa. Japan. Jpn J Med 1988, 27:142-149.
30. Poynard T., Ratziu V., Naveau S., Thabut D., Charlotte F., Messous D., Capron D., Abella A., Massard J., Ngo Y., Munteanu M., Mercadier A., Manns M., Albrecht J. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005, 4:10.
31. R Development Core Team R: A Language and Environment for Statistical Computing. R Fundation for Statistical Computing 2008.
32. Ratziu V., Bonyhay L., Di Martino V., Charlotte F., Cavallaro L., Sayegh-Tainturier M.H., Giral P., Grimaldi A., Opolon P., Poynard T. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485-1493.
33. Ratziu V., Charlotte F., Heurtier A., Gombert S., Giral P., Bruckert E., Grimaldi A., Capron F., Poynard T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005, 128:1898-1906.
34. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., Christidis C., Ziol M., Poulet B., Kazemi F., Beaugrand M., Palau R. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003, 29:1705-1713.
35. Sandrin L., Tanter M., Gennisson J.L., Catheline S., Fink M. Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control 2002, 49:436-446.
36. Schwenzer N.F., Springer F., Schraml C., Stefan N., Machann J., Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009, 51:433-445.
37. Siegel S., Castellan J. Nonparametric statistics for the behavioral sciences 1988, McGraw-Hill, New York.
38. Steyerberg E.W., Harrell F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., Habbema J.D. Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
39. Szabo T.L. Diagnostic ultrasound imaging: Inside out 2004, Elsevier Academic Press, Amsterdam.
40. Taylor K.J., Riely C.A., Hammers L., Flax S., Weltin G., Garcia-Tsao G., Conn H.O., Kuc R., Barwick K.W. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: Importance of fat. Radiology 1986, 160:65-71.
41. Wagner R.F., Smith S.W., Sandrik J.M., Lopez H. Statistics of speckle in ultrasound B-scans. IEEE Trans Sonic Ultrason 1983, 30:156-163.
42. Westerbacka J., Lammi K., Hakkinen A.M., Rissanen A., Salminen I., Aro A., Yki-Jarvinen H. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005, 90:2804-2809.
43. Wilson L.S., Robinson D.E., Griffiths K.A., Manoharan A., Doust B.D. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver. Ultrason Imaging 1987, 9:236-247.
44. Wong V.W., Vergniol J., Wong G.L., Foucher J., Chan H.L., Le Bail B., Choi P.C., Kowo M., Chan A.W., Merrouche W., Sung J.J., de Ledinghen V. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in non-alcoholic liver disease. Hepatology 2010, 51:454-462.
45. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., de Ledinghen V., Marcellin P., Dhumeaux D., Trinchet J.C., Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005, 41:48-54.